Cheaper anti-stroke drug in the offing
Also See:– Urban poor income in AP too low
VIJAYAWADA: In a landmark development, a drug that is expected to drastically bring down the stroke treatment cost, has successfully cleared the trial stage and is all set to enter the market. The drug trials carried out on about 75 stroke patients across the country has been found satisfactory by the Drug Control General of India (DCGI).
He said that the single dose of the existing drugs used to normalize the physical condition of a stroke patient costs around Rs 66,000 while the latest drug is expected to cost just Rs 28,000. He said that tenecteplase helps defuse the blood clot in the brain and give a lease of life to the victims.
“This could revolutionize the treatment of stroke patients in the country as the majority of the victims are keeping away from the hospital for fear of high costs involved in the treatment,” observed chief of Aster Ramesh hospitals group, Dr Ramesh Babu.